Adbi, A, Chatterjee, C., Drev, M., & Mishra, A. (2018). When the Big One Came: A Natural Experiment on Demand Shocks and Market Structure in India's Influenza Vaccine Markets. Accepted and forthcoming, Production and Operations Management.
 Adbi, A., Bhaskarabhatla, A.S., Chatterjee, C. (2018). Stakeholder Orientation and Market Impact: Evidence from India. Journal of Business Ethics.
 Chatterjee, C., Joshi, R., Sood, N., & Boregowda, P. (2018). Government health insurance and spatial peer effects: New evidence from India. Social Science & Medicine, 196, 131-141.
 Chakraborty, P. & Chatterjee, C. (2017). Does Environmental Regulation Indirectly Induce Upstream Innovation? New Evidence from India. Research Policy, 46(5), 939-955.
 Bhaskarabhatla, A., & Chatterjee, C. (2017). The role of physicians in prescribing irrational fixed-dose combination medicines in India. Social Science & Medicine, 174, 179-187.
 Bhaskarabhatla, A. Chatterjee, C., Anurag, P., Pennings, E. (2017). Mitigating regulatory impact: the case of partial price controls on metformin in India. Health Policy and Planning, 32 (2), 194-204.
 Bhaskarabhatla, A., & Chatterjee, C. (2017). Whither competition law in Indian pharmaceutical markets? Evidence from arbitration data of CCI and COMPAT. Journal of Antitrust Enforcement.
 Adbi, A., Faizi, N., & Chatterjee, C. (2017). Analyzing the Lazy Mother Argument Inspired by the Maggi Controversy. Economic & Political Weekly, 52(28), 49.
 Branstetter, L., Chatterjee, C., & Higgins, M. J. (2016). Regulation and welfare: evidence from paragraph IV generic entry in the pharmaceutical industry. The RAND Journal of Economics, 47(4), 857-890. NBER Working Paper 17188.
 Bhaskarabhatla, A., Chatterjee, C. Bas Karreman (2016). Hit where it hurts: Cartel policing using targeted sales embargoes in markets for medicines. The Journal of Law & Economics, 59(4), 805-846.
 Pingali, V., Chaudhuri, M.K., Malik, P., Tamara, R., Kakkar, A. Chatterjee, C., Mondal, S., Sokol, D. Daniel. (2016). Competition Law in India: Perspectives. Vikalpa 41: 168-193.
 Chatterjee, C., Kubo, K., & Pingali, V. (2015). The consumer welfare implications of governmental policies and firm strategy in markets for medicines. Journal of Health Economics, 44, 255-273.
 Chatterjee, C., Pingali, V. (2015). Balancing Affordability and Availability in a Drug Patent Regime. Economic & Political Weekly, 50(41), 20-23.
 Chatterjee, C., Kubo, K., Pingali, V. (2013). Crocin or paracetamol – What should the doctor prescribe. Economic & Political Weekly Vol - XLVIII No. 41.
Case Studies & Book Chapters:
 Roposo.com: Share Your Style: Entrepreneurial Pivoting & Strategic Thinking in Indian Fashion Social Networking - Harvard Business Publishing Case Study (with Reechal Vardhan and available here).
 Chatterjee, C. & Mahendiran, S. (2017). The emerging market for biological drugs in India. India & Innovation, Oxford University Press (India) & University of Pennsylvania.
 Chatterjee, C. (2009). The historical evolution of post-TRIPs modern Indian pharmaceuticals. Prescribing cultures and pharmaceutical policy. Asia-Pacific 2009, K. Eggleston ed. Walter H. Shorenstein Asia-Pacific Research Center, The Brookings Press.